Similar Papers

Paper Title
Journal
Date
Author
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
Laila König ... Juliane Hörner-Rieber
Frontiers in Oncology | VOL. 10
Laila König, et. al.Laila König ... Juliane Hörner-Rieber
07 Jul 2020
Risk of Secondary Hematological Malignancies in Patients with Follicular Lymphoma: A Retrospective Analysis of 1045 Patients Treated in the Rituximab Era
Roosa Enni Inkeri Prusila ... Outi Kuittinen
Blood | VOL. 132
Roosa Enni Inkeri Prusila, et. al.Roosa Enni Inkeri Prusila ... Outi Kuittinen
29 Nov 2018
RISK OF SECONDARY HEMATOLOGICAL MALIGNANCY IN PATIENTS WITH FOLLICULAR LYMPHOMA
R Prusila ... S Tikkanen
Hematological Oncology | VOL. 35
R Prusila, et. al.R Prusila ... S Tikkanen
01 Jun 2017
Predicting the risk of secondary malignancies associated with stereotactic body radiation therapy.
David Paul Horowitz ... K S Clifford Chao
Journal of Clinical Oncology | VOL. 30
David Paul Horowitz, et. al.David Paul Horowitz ... K S Clifford Chao
20 May 2012
View more papers

More From: Clinical Lymphoma, Myeloma and Leukemia

Paper Title
Journal
Date
Author
Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Jing Christine Ye ... Anil Londhe
Clinical Lymphoma, Myeloma and Leukemia | VOL. 25
Jing Christine Ye, et. al.Jing Christine Ye ... Anil Londhe
01 Feb 2025
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
Andrew H Lipsky ... Nicole Lamanna
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Andrew H Lipsky, et. al.Andrew H Lipsky ... Nicole Lamanna
01 Dec 2024
Table of Contents
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
A phase I study of romidepsin in combination with gemcitabine, oxaliplatin, and dexamethasone in patients with relapsed or refractory aggressive lymphomas enriched for T-cell lymphomas.
Nicole Foley ... Neha Mehta-Shah
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Nicole Foley, et. al.Nicole Foley ... Neha Mehta-Shah
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.